help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 5, 2007, doi:10.1164/rccm.200608-1189OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200608-1189OCv1
175/12/1280    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taraseviciene-Stewart, L.
Right arrow Articles by Voelkel, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taraseviciene-Stewart, L.
Right arrow Articles by Voelkel, N. F.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 1280-1289, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200608-1189OC


Original Article

Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling

Laimute Taraseviciene-Stewart1,*, Mark R. Nicolls1,*, Donatas Kraskauskas1, Robertas Scerbavicius1, Nana Burns1, Carlyne Cool2, Kathy Wood2, Jane E. Parr2, Susan A. Boackle3 and Norbert F. Voelkel1

1 Division of Pulmonary Sciences, Department of Medicine, 2 Department of Pathology, and 3 Division of Rheumatology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to Laimute Taraseviciene-Stewart, Ph.D., Division of Pulmonary Sciences and Critical Care Medicine, 4200 East Ninth Avenue, C272, Denver, CO 80262. E-mail: laima.taraseviciene{at}uchsc.edu

Rationale: Severe pulmonary arterial hypertension (SPH) is a frequently lethal condition characterized by pulmonary vascular remodeling and right heart strain or failure. SPH is also often associated with autoimmune and collagen vascular disorders.

Objectives: To study the effects of T cells on the development of experimental SPH.

Methods: Athymic nude rats lacking T cells were treated with a single subcutaneous injection of vascular endothelial growth factor (VEGF) receptor blocker SU5416 (20 mg/kg) to induce pulmonary vascular endothelial cell apoptosis. Immunohistochemical analysis and IL-4 levels of the lung tissue were performed. Cell death and proliferation were assessed by Western blot and immunohistochemistry.

Measurements and Main Results: In contrast to SU5416-treated euthymic rats that develop SPH only in combination with chronic hypoxia, athymic nude rats developed SPH and vascular remodeling (similar to clinical SPH) at normoxic conditions as demonstrated by measurements of pulmonary artery pressure and right ventricle hypertrophy. Pulmonary arterioles became occluded with proliferating endothelial cells and were surrounded by mast cells, B cells, and macrophages. IL-4, proliferating cell nuclear antigen, and collagen type I levels were markedly increased in SU5416-treated athymic rat lungs. Antibody deposition was noted along the vascular endothelium in rats with SPH. Finally, protection from SPH was conferred by immune challenge with spleen cells from euthymic nude rats.

Conclusions: These studies demonstrate the importance of a complete, intact immune system in protecting against pulmonary angioproliferation in this new model of SPH as well as the importance of intact VEGF receptor signaling for lung endothelial cell homeostasis.

Key Words: pulmonary hypertension • T cells • apoptosis • proliferation


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
There is no experimental model of immune mechanism–dependent severe pulmonary hypertension.

What This Study Adds to the Field
T-cell deficiency confers increased pulmonary arterial hypertension and vascular remodeling.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
P. R. Rai, C. D. Cool, J. A. C. King, T. Stevens, N. Burns, R. A. Winn, M. Kasper, and N. F. Voelkel
The Cancer Paradigm of Severe Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 558 - 564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Arterial Hypertension 2007
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 574 - 579.
[Full Text] [PDF]


Home page
J. Exp. Med.Home page
E. Daley, C. Emson, C. Guignabert, R. de Waal Malefyt, J. Louten, V. P. Kurup, C. Hogaboam, L. Taraseviciene-Stewart, N. F. Voelkel, M. Rabinovitch, et al.
Pulmonary arterial remodeling induced by a Th2 immune response
J. Exp. Med., February 18, 2008; 205(2): 361 - 372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva
Inflammation and ischemia-induced lung angiogenesis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. R. Bauer, T. M. Moore, and I. F. McMurtry
Rodent models of PAH: are we there yet?
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L580 - L582.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008